Physicians who participate in telehealth/telemedicine have an ethical responsibility to uphold fundamental fiduciary obligations by disclosing any financial or other interests the physician has in the telehealth/telemedicine application or service, and take steps to manage or eliminate conflicts of interests. Whenever they provide health information, including health content for websites or mobile health applications, physicians must ensure that the information they provide or that is attributed to them is objective and accurate.
Similarly, all physicians who participate in telehealth/telemedicine must assure themselves that telemedicine services have appropriate protocols to prevent unauthorized access and to protect the security and integrity of patient information at the patient end of the electronic encounter, during transmission, and among all health care professionals and other personnel who participate in the telehealth/telemedicine service consistent with their roles.
Physicians who respond to individual health queries or provide personalized health advice electronically through a telehealth service also should:
(a) Inform users about the limitations of the relationship and services provided.
(b) Advise site users about how to arrange for needed care when follow-up care is indicated.
(c) Encourage users who have primary care physicians to inform their primary physicians about the online health consultation, even if in-person care is not immediately needed.
(d) Be proficient in the use of the relevant technologies and comfortable interacting with patients and/or surrogates electronically.
(e) Recognize the limitations of the relevant technologies and take appropriate steps to overcome those limitations. Physicians must ensure that they have the information they need to make well-grounded clinical recommendations when they cannot personally conduct a physical examination, such as by having another healthcare professional at the patient’s site conduct the exam or obtaining vital information through remote technologies.
(f) Be prudent in carrying out a diagnostic evaluation or prescribing medication by:
- Establishing the patient’s identity
- Confirming that telehealth/telemedicine services are appropriate for that patient’s situation and medical needs
- Evaluating the indication, appropriateness, and safety of any prescription in keeping with best practice guidelines and any formulary limitations that apply to the electronic interaction
- Documenting the clinical evaluation and prescription
(g) When the physician would otherwise be expected to obtain informed consent, tailor the informed consent process to provide information patients (or their surrogates) need about the distinctive features of telehealth/telemedicine, in addition to information about medical issues and treatment options. Patients and surrogates should have a basic understanding of how telemedicine technologies will be used in care, the limitations of those technologies, the credentials of health care professionals involved, and what will be expected of patients for using these technologies.
(h) As in any patient-physician interaction, take steps to promote continuity of care, considering how information can be preserved and accessible for future episodes of care in keeping with patients’ preferences (or the decisions of their surrogates), and how follow-up care can be provided when needed. Physicians should assure themselves how the information will be conveyed to the patient’s primary care physician when the patient has a primary care physician and to other physicians currently caring for the patient.
Collectively, through their professional organizations and healthcare institutions, physicians should:
- Support ongoing refinement of telehealth/telemedicine technologies and the development and implementation of clinical and technical standards to ensure the safety and quality of care.
- Advocate for policies and initiatives to promote access to telehealth/telemedicine services for all patients who could benefit from receiving care electronically.
(k) Routinely monitor the telehealth/telemedicine landscape to:
- Identify and address adverse consequences as technologies and activities evolve
- Identify and encourage dissemination of both positive and negative outcomes